On the other hand, we see an increase in risk-weighted assets up to the crisis, with a slight drop afterwards and the trend steadying since then. The deal will free up capital of some EUR 400 million, primarily by reducing risk-weighted assets by EUR 4.
The Heska Corporation is involved in biotechnical research for the development of vaccines and related diagnostic products for companion animals. The company manufactures health care products for dogs, cats, and horses and markets them to veterinarians.
HEINEKEN is the UKâs leading cider and beer producer and the name behind iconic drinks brands such as Strongbow, Bulmers, HeinekenÂ®, Foster's, Kronenbourg 1664 and Desperados, together with a full range of speciality brands.